Endpoints of clinical trials in invasive bladder cancer.
Tannock
I F
IF
Department of Medicine, Princess Margaret Hospital, Toronto, Ontario, Canada.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000379:methods*; D006801:Humans; D009361:Neoplasm Invasiveness; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D015996:Survival Rate; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000401:mortality